Gastric juice: a barrier against infectious diseases.
暂无分享,去创建一个
[1] A. Blum,et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. , 1994, Gut.
[2] J. Beynon,et al. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity , 1999, Gut.
[3] D. Bogchelman,et al. TRIPLET PREGNANCY AFTER PULSATILE ADMINISTRATION OF GONADOTROPIN RELEASING HORMONE , 1982, The Lancet.
[4] P. Mackowiak,et al. The human gastric bactericidal barrier: mechanisms of action, relative antibacterial activity, and dietary influences. , 1989, The Journal of infectious diseases.
[5] A. Webster,et al. Microbial and metabolic profile of achlorhydric stomach: comparison of pernicious anaemia and hypogammaglobulinaemia. , 1985, Journal of clinical pathology.
[6] N. Zamcheck,et al. Salmonella enteritis , 1971, The American Journal of Digestive Diseases.
[7] R. Holder,et al. Increased incidence of bacterial diarrhoea in patients taking gastric acid antisecretory drugs , 1994 .
[8] G. Guyatt,et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.
[9] G. Friedland,et al. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. , 1986, Archives of internal medicine.
[10] D. Cook,et al. Gastric alkalinization, pneumonia, and systemic infections: the controversy. , 1995, Scandinavian journal of gastroenterology. Supplement.
[11] S. Winawer,et al. Clinical Giardiasis and Intestinal Malabsorption , 1967 .
[12] P. Arnow,et al. Brucellosis in a group of travelers to Spain. , 1984, JAMA.
[13] J. Aponte,et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia , 2002, American Journal of Gastroenterology.
[14] Walsh,et al. Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors , 2000, Alimentary pharmacology & therapeutics.
[15] J. Peters,et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids , 2007, Journal of Gastrointestinal Surgery.
[16] R. Slack,et al. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study , 1996, BMJ.
[17] D. Nalin,et al. CHOLERA, NON-VIBRIO CHOLERA, AND STOMACH ACID , 1978, The Lancet.
[18] F. Cipollini,et al. Candidiasis of the small intestine. , 1981, Gastroenterology.
[19] A. Larner,et al. Oesophageal candidiasis after omeprazole therapy. , 1992, Gut.
[20] C. Mowat,et al. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. , 1999, Gastroenterology.
[21] A. Johnsen. Phylogeny of the Cholecystokinin/Gastrin Family , 1998, Frontiers in Neuroendocrinology.
[22] B. Celli,et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. , 1987, The New England journal of medicine.
[23] G. Young,et al. A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH , 1996, Journal of bacteriology.
[24] A. Boussuges,et al. Evaluation of left ventricular filling pressure by transthoracic Doppler echocardiography in the intensive care unit , 2002, Critical care medicine.
[25] J. Hawkey,et al. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for salmonella infection , 1994, BMJ.
[26] I. Barker,et al. Gastric dysfunction in sheep infected with Trichostrongylus colubriformis, a nematode inhabiting the small intestine. , 1982, International journal for parasitology.
[27] Henry J. Bartle,et al. THE GASTRIC SECRETION: ITS BACTERICIDAL VALUE TO MAN , 1925 .
[28] R. P. Thompson,et al. Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy. , 1986, Gut.
[29] R. Wenzel,et al. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. , 1974, The Journal of infectious diseases.
[30] S. Bhatia,et al. Gastric bacterial overgrowth accompanies profound acid suppression. , 1995, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[31] A. Stenderup,et al. Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. , 1988, Scandinavian journal of gastroenterology.
[32] T. Inglis,et al. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung , 1993, The Lancet.
[33] R. Stockbruegger. Bacterial overgrowth as a consequence of reduced gastric acidity. , 1985, Scandinavian journal of gastroenterology. Supplement.
[34] E. C. Wood,et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. , 1984, British medical journal.
[35] D. Youngs,et al. Cimetidine and the potential risk of postoperative sepsis , 1981, The British journal of surgery.
[36] A. Ruigómez,et al. Gastric Acid, Acid‐Suppressing Drugs, and Bacterial Gastroenteritis: How Much of a Risk? , 1997, Epidemiology.
[37] R. Russell,et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. , 1994, Gastroenterology.
[38] J. Gray,et al. Severe Salmonella Gastroenteritis Associated with Hypochlorhydria , 1971, Scottish medical journal.
[39] N. Blacklow,et al. Abnormal gastric motor function in viral gastroenteritis. , 1980, Annals of internal medicine.
[40] F. Cobelens,et al. Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. , 1998, Tropical medicine & international health : TM & IH.
[41] C. Mowat,et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.
[42] B. Drasar,et al. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. , 1969, Gastroenterology.
[43] B. Marshall,et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. , 1990, Gastroenterology.
[44] J. Hendel,et al. Omeprazole in the long‐term treatment of severe gastro‐oesophageal reflux disease in patients with systemic sclerosis , 1992, Alimentary pharmacology & therapeutics.
[45] M. Blaser,et al. Experimental Campylobacter jejuni infection in humans. , 1988, The Journal of infectious diseases.
[46] G. Cook. Hypochlorhydria and vulnerability to intestinal infection , 1994 .
[47] Katz,et al. Gastro‐oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors , 1998, Alimentary pharmacology & therapeutics.
[48] C. Evans,et al. Gastric acid secretion and enteric infection in Bangladesh. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[49] S. Lichtman,et al. Small bowel bacterial overgrowth syndrome. , 1987, Digestive diseases.
[50] K. Tobita,et al. Detection of type B influenza virus genes from biopsied gastric mucosa , 2002, Journal of Gastroenterology.
[51] J. Aponte,et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis , 2001, American Journal of Gastroenterology.
[52] Craig Williams,et al. Occurrence and significance of gastric colonization during acid-inhibitory therapy. , 2001, Best practice & research. Clinical gastroenterology.
[53] G. Guyatt,et al. A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical Ventilation , 1999 .
[54] A. Sandvik,et al. Histamine and the stomach. , 1989, Scandinavian journal of gastroenterology.
[55] J. Haas,et al. Zum Krankheitswert der Lamblien-Infektion* , 1967 .
[56] F. Paradisi,et al. CAN CIMETIDINE FACILITATE INFECTIONS BY ORAL ROUTE? , 1982, The Lancet.
[57] G. Simon,et al. Intestinal flora in health and disease. , 1984, Gastroenterology.
[58] R. Steffen. Antacids--a risk factor in travellers brucellosis? , 1977, Scandinavian journal of infectious diseases.
[59] A. Sandvik,et al. Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections , 2002, Expert opinion on drug safety.
[60] Xiang Xu,et al. Peripheral regulation of gastric acid secretion , 2000 .
[61] R. D. De Lisle,et al. Decreased Gastric Bacterial Killing and Up-Regulation of Protective Genes in Small Intestine in Gastrin-Deficient Mouse , 2003, Digestive Diseases and Sciences.
[62] E. H. Ellison,et al. An analysis of ten cases of Salmonella infection on a general surgical service. , 1960, Archives of surgery.
[63] B. D. Pimparkar,et al. Anaemia and gastro-intestinal function in ancylostomiasis. , 1982, Journal of Postgraduate Medicine.
[64] J. Goepel,et al. SYSTEMIC CANDIDIASIS COMPLICATING ACUTE HEPATIC FAILURE IN PATIENTS TREATED WITH CIMETIDINE , 1981, The Lancet.
[65] R. Logan,et al. Potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors , 2001, Alimentary pharmacology & therapeutics.
[66] M. Hill,et al. EFFECT OF CIMETIDINE ON THE GASTRIC BACTERIAL FLORA , 1980, The Lancet.
[67] E. DeMaria,et al. Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial. , 1990, The Journal of trauma.
[68] S. O'keefe,et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole , 1996, Alimentary pharmacology & therapeutics.
[69] Girdwood Rh,et al. BACTERIAL CHANGES IN THE SMALL INTESTINE IN MALABSORPTIVE STATES AND IN PERNICIOUS ANAEMIA. , 1964 .
[70] A. Andriulli,et al. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. , 1983, Digestion.
[71] H. F. Smith,et al. Bacteriology of the Stomach Immediately Following Vagotomy: The Growth of Candida Albicans , 1974, Annals of surgery.
[72] G. Cook. Infective gastroenteritis and its relationship to reduced gastric acidity. , 1985, Scandinavian journal of gastroenterology. Supplement.
[73] A. Haddow,et al. BLOOD-GROUP AND DISEASE. , 1964, Lancet.
[74] Sokolova Em. SALMONELLA DERBY INFECTIONS AFTER GASTROINTESTINAL SURGERY. , 1965 .
[75] Andrew F. Hill,et al. The same prion strain causes vCJD and BSE , 1997, Nature.
[76] A. Hurst. THE CLINICAL IMPORTANCE OF ACHLORHYDRIA * , 1934, British medical journal.
[77] J. Foster,et al. OmpR Regulates the Stationary-Phase Acid Tolerance Response of Salmonella enterica Serovar Typhimurium , 2000, Journal of bacteriology.
[78] D. Wingate. Acid reduction and recurrent enteritis , 1990, The Lancet.
[79] D. Taylor,et al. Gastric Acidity Protects Mice Against Prion Infection? , 2002, Scandinavian journal of gastroenterology.
[80] H. Berglund,et al. Transitory Character of the Achlorhydria During Fever Demonstrated by the Histamine Test. , 1929 .
[81] A. Aguzzi. Peripheral prion pursuit. , 2001, The Journal of clinical investigation.
[82] L. Gottlieb,et al. Strongyloidiasis at the boston city hospital , 1968, The American Journal of Digestive Diseases.
[83] R. Laheij,et al. Gastric acid‐suppressive therapy and community‐acquired respiratory infections , 2003, Alimentary pharmacology & therapeutics.
[84] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[85] C. Spirig,et al. Bactericidal factors in gastric juice , 1992 .
[86] S. Broitman,et al. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro , 1972, Gut.
[87] S. Sarker,et al. Non-immunological defence mechanisms of the gut. , 1992, Gut.
[88] A. L. Kruger. Gastric acidity in pulmonary tuberculosis , 1943 .
[89] S. Ghosh,et al. Prion proteins and the gut: une liaison dangereuse? , 2001, Gut.
[90] C. Carpenter,et al. Experimental canine cholera. I. Development of the model. , 1969, The Journal of infectious diseases.
[91] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[92] L. Nyhus,et al. Inhibition of Gastric Acid Secretion by Bacterial Lipopolysaccharide , 1967, Nature.
[93] Michael A. Rodriguez,et al. Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru , 2000, The Lancet.
[94] A. Blum,et al. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. , 1994, Gut.
[95] A. Sabin. Pathogenesis of poliomyelitis; reappraisal in the light of new data. , 1956, Science.
[96] Nelis,et al. Atrophic gastritis during long‐term omeprazole therapy affects serum vitamin B12 levels , 1999, Alimentary pharmacology & therapeutics.
[97] B. Dale,et al. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. , 2003, The Journal of hospital infection.
[98] F. Collins. Salmonellosis in Orally Infected Specific Pathogen-Free C57B1 Mice , 1972, Infection and immunity.
[99] O. Berger. Ueber die ätiologischen Beziehungen zwischen Syphilis und Tabes , 1885 .
[100] A. Berstad,et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks , 1999, BMJ.
[101] M. Shiner,et al. Influence of gastric pH on gastric and jejunal flora. , 1967, Gut.
[102] L. Laine. Reply–potential gastrointestinal effects of longterm acid suppression with proton pump inhibitors , 2001 .
[103] J. Cadranel,et al. Another example of Strongyloides stercoralis infection associated with cimetidine in an immunosuppressed patient. , 1986, Gut.
[104] S. Cousens,et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.
[105] W. Waddell,et al. Association of Salmonella enteritis with operations on the stomach. , 1956, The New England journal of medicine.
[106] Stolte,et al. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.
[107] A. Blum,et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. , 1996, Gastroenterology.
[108] G. Ruiz-Irastorza,et al. Risk Factors for Esophageal Candidiasis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[109] H. Clark,et al. Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice. , 1985, The Journal of general virology.
[110] M. Rousseau,et al. Association between pulmonary and digestive infections in patients receiving gastric acid-lowering medications for a long duration , 2003, Brain injury.
[111] Sunoto,et al. The stomach in malnutrition. , 1977, Archives of disease in childhood.
[112] T E Woodward,et al. The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. , 1971, Bulletin of the New York Academy of Medicine.
[113] A. Blum,et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. , 1996, Gut.
[114] H. Dupont,et al. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. , 1972, The Journal of infectious diseases.
[115] O. James,et al. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. , 1983, British medical journal.
[116] A. Sandvik,et al. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. , 1991, The American journal of physiology.
[117] J. Larner,et al. Review article: infective complications of therapeutic gastric acid inhibition , 1994, Alimentary pharmacology & therapeutics.
[118] M. Dilworth,et al. Problems of adverse pH and bacterial strategies to combat it. , 1999, Novartis Foundation symposium.
[119] P. Lundborg,et al. Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects. , 1993, Scandinavian journal of gastroenterology.
[120] Lamers,et al. Interdigestive antroduodenal motility and gastric acid secretion , 1998, Alimentary pharmacology & therapeutics.
[121] D. Owen. Attempts at oral infection of rats and mice with trophozoites of Entamoeba histolytica. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[122] R. Dowling,et al. Drug‐induced hypochlorhydria causes high duodenal bacterial counts in the elderly , 1998, Alimentary pharmacology & therapeutics.
[123] S. Gitelson. Gastrectomy, achlorhydria and cholera. , 1971, Israel journal of medical sciences.
[124] S. Khosla,et al. Gastric acid secretion in typhoid fever. , 1993, Postgraduate medical journal.
[125] JAMES L. Smith,et al. The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions. , 2003, Journal of food protection.
[126] P. Cotton,et al. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. , 1982, Gut.
[127] C. Gahan,et al. The relationship between acid stress responses and virulence in Salmonella typhimurium and Listeria monocytogenes. , 1999, International journal of food microbiology.
[128] S. Broitman,et al. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. , 1973, Annals of internal medicine.
[129] J. Walsh,et al. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. , 1975, The Journal of clinical investigation.
[130] R. Wood,et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. , 1995, Journal of the American College of Nutrition.
[131] A. Aguzzi. Neuro-immune connection in spread of prions in the body? , 1997, The Lancet.
[132] R. Hunt,et al. Relationship between gastric secretion and infection. , 1987, Gut.
[133] K. Steinberg. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. , 2002, Critical care medicine.